Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of INC Research Holdings Inc (NASDAQ: INCR) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of INC Research Holdings Inc (NASDAQ: INCR) concerning whether a series of statements by INC Research Holdings Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On November 9, 2017, the Company reported its first financial results after combining with inVentiv Health. The Company’s combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses.

On this news, NASDAQ: INCR fell $16.35 per share, or 28.43%, to close at $41.15 on November 9, 2017.

Based in Raleigh, North Carolina, and founded in 2010 INC Research Holdings Inc provides various clinical development services for the biopharmaceutical and medical device industries in North America, Europe, the Middle East and Africa, the Asia-Pacific, and Latin America.

If you purchased shares of INC Research Holdings Inc (NASDAQ: INCR) on or before November 9, 2017, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185